Atul Pande, Director at Karuna Therapeutics, Inc. (KRTX), sold 11,428 shares at $92.64 ($1.1M) on 2020-12-14, disclosed to the SEC on 2020-12-14.
Open-market sale of $1.1M KRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.64 | 5,714 | $529K | 50.0% |
| 2 | $92.64 | 5,714 | $529K | 50.0% |
| Total | $92.64 avg | 11,428 | $1.1M | 100% |
| Filing → |
| IMVT | SELL | 2026-06-26 | $57K | — | Filing → |
| IMVT | SELL | 2026-06-16 | $51K | — | Filing → |
| IMVT | SELL | 2026-05-20 | $192K | — | Filing → |